RxDoctor Payments DataLook up a doctor →

John Dorsey, PA

Physician Assistant · Phoenix, AZNPI 1114392800

Payments from drug & device makers

$17,400in general payments, 2019–2025

Across 732 payments — averaging $23.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$6K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
  • Takeda Pharmaceuticals U.S.A., Inc.$1K
  • Madrigal Pharmaceuticals$963
  • Johnson & Johnson$915
  • Gilead$647
  • plus $6K from 34 others

What the payments were for

  • Food & beverage$17,26599%
  • Education$630%
  • Gifts$720%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,400 in reported general payments places this provider in the 95th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$124,204
Medicare patients
695
Services billed
1,888

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide108$87,946
CreonLipase/Protease/Amylase18$62,555
XifaxanRifaximin12$27,709
TrulancePlecanatide21$19,746
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates233$15,024
Dexlansoprazole DrDexlansoprazole30$11,674
Mesalamine27$11,010
MovantikNaloxegol Oxalate13$9,428
Pantoprazole Sodium274$4,077
Mesalamine ErMesalamine18$4,036
SutabSod Sulf/Pot Chloride/Mag Sulf24$3,946
Sucralfate52$3,173
Colestipol Hcl15$2,944
Omeprazole205$2,739
Budesonide DrBudesonide26$1,912

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Creon$5,510$150,501126 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance$1,855$47,45633 claims
Redhill Biopharma Inc.Movantik$21$9,42813 claims
Braintree Laboratories, Inc.Sutab$202$3,94624 claims
Ferring Pharmaceuticals Inc.Clenpiq$196$1,87611 claims
SandozLansoprazole$50$54114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →